SCHEMBL883653

SCHEMBL883653

Cc1cccc(-c2cccc(C(=O)c3ccccc3)c2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 4/20 0.71
CNR1 P21554 1/20 0.69
ATM Q13315 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
POLB P06746 2/20 0.57
DHODH Q02127 1/20 0.55
KMO O15229 1/20 0.53
MAPT P10636 1/20 0.53
CTDSP1 Q9GZU7 1/20 0.53
HDAC2 Q92769 1/20 0.52
ALDH1A1 P00352 2/20 0.52
PBRM1 Q86U86 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.51
HSD17B1 P14061 1/20 0.51
HSD17B2 P37059 1/20 0.51
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MAPK13 O15264 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6019106 0.91 CNR2 (0.69) CNR2CNR1ATMTDP1L3MBTL1
SCHEMBL29658753 0.88 ATM (0.71) CNR2CNR1ATMTDP1L3MBTL1
SCHEMBL81347 0.88 ATM (0.71) CNR2CNR1ATMTDP1L3MBTL1
SCHEMBL8438374 0.88 ATM (0.77) CNR2ATMTDP1L3MBTL1KMO
SCHEMBL194537 0.87 CNR2 (0.69) CNR2CNR1ATMTDP1L3MBTL1
SCHEMBL29490805 0.87 CNR2 (0.69) CNR2CNR1ATMTDP1L3MBTL1
SCHEMBL6464883 0.87 CNR2 (0.60) CNR2CNR1ATMTDP1L3MBTL1
SCHEMBL12906721 0.87 CNR2 (0.65) CNR2CNR1ATMTDP1L3MBTL1
Benzophenone SCHEMBL11756762 0.86 ATM (0.67) CNR2CNR1ATMTDP1L3MBTL1
SCHEMBL11183749 0.86 ATM (0.74) CNR2ATMTDP1L3MBTL1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 US disclosed
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 US disclosed
US-20220336752-A1 Organic Electroluminescent Element, Material for Organic Electroluminescent Element, Light Emitting Device, Display Device and Lighting Device Each Using Said Element, and Compound Used for Said Element UDC IRELAND LIMITED (IE) 2022-10-20 US disclosed
US-11171293-B2 Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element UDC IRELAND LIMITED (IE) 2021-11-09 US disclosed
US-20190280218-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2019-09-12 US disclosed
US-10374170-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2019-08-06 US disclosed
EP-2651862-B1 SUBSTITUTED TETRAARYLBENZENES MERCK PATENT GMBH (DE) 2017-05-10 EP disclosed
US-9598637-B2 Phosphorus-containing metal complexes MERCK PATENT GMBH (DE) 2017-03-21 US disclosed
US-9598637-B2 Phosphorus-containing metal complexes MERCK PATENT GMBH (DE) 2017-03-21 US disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 US disclosed
US-8906893-B2 Substituted tetraarylbenzenes MERCK PATENT GMBH (DE) 2014-12-09 US disclosed
US-20140319507-A1 Organic Electroluminescent Element, Material for Organic Electroluminescent Element, Light Emitting Device, Display Device and Lighting Device Each Using Said Element, and Compound Used for Said Element UDC IRELAND LIMITED (IE) 2014-10-30 US disclosed
US-20140319507-A1 Organic Electroluminescent Element, Material for Organic Electroluminescent Element, Light Emitting Device, Display Device and Lighting Device Each Using Said Element, and Compound Used for Said Element UDC IRELAND LIMITED (IE) 2014-10-30 US disclosed
US-20130261708-A1 SUBSTITUTED TETRAARYLBENZENES MERCK PATENT GMBH (DE) 2013-10-03 US disclosed
US-20130261708-A1 SUBSTITUTED TETRAARYLBENZENES MERCK PATENT GMBH (DE) 2013-10-03 US disclosed
US-20130253617-A1 PHOSPHORUS-CONTAINING METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-09-26 US disclosed
US-20130253617-A1 PHOSPHORUS-CONTAINING METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-09-26 US disclosed
WO-2012107163-A1 SUBSTITUTED DIBENZONAPHTHACENE MERCK PATENT GMBH (DE) 2012-08-16 WO disclosed
WO-2012079678-A1 SUBSTITUTED TETRAARYLBENZENES MERCK PATENT GMBH (DE) 2012-06-21 WO disclosed
WO-2012038029-A1 PHOSPHORUS-CONTAINING METAL COMPLEXES MERCK PATENT GMBH (DE) 2012-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917913-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 CNR2 400/4885CNR1 1130/4885ATM 1550/4885
US-20220336752-A1 Organic Electroluminescent Element, Material for Organic Electroluminescent Element, Light Emitting Device, Display Device and Lighting Device Each Using Said Element, and Compound Used for Said Element L1CAM, NR2E3, OR10J3 CNR2 2368/4885CNR1 2479/4885ATM 2619/4885
US-10374170-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 CNR2 400/4885CNR1 1130/4885ATM 1550/4885
US-20190280218-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 CNR2 400/4885CNR1 1130/4885ATM 1550/4885
US-11171293-B2 Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element L1CAM, OR10J3, INTS9 CNR2 3013/4885CNR1 2805/4885ATM 2547/4885
US-20160308146-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 CNR2 400/4885CNR1 1130/4885ATM 1550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.